EP3082478A1 - Methods for reducing matrix-bound nicotine-derived nitrosamine ketone in tobacco plant material - Google Patents
Methods for reducing matrix-bound nicotine-derived nitrosamine ketone in tobacco plant materialInfo
- Publication number
- EP3082478A1 EP3082478A1 EP14824834.7A EP14824834A EP3082478A1 EP 3082478 A1 EP3082478 A1 EP 3082478A1 EP 14824834 A EP14824834 A EP 14824834A EP 3082478 A1 EP3082478 A1 EP 3082478A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tobacco
- matrix
- plant material
- amount
- nnk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 472
- 244000061176 Nicotiana tabacum Species 0.000 title claims abstract description 405
- 239000000463 material Substances 0.000 title claims abstract description 245
- 239000011159 matrix material Substances 0.000 title claims abstract description 153
- 238000000034 method Methods 0.000 title claims abstract description 140
- 230000001603 reducing effect Effects 0.000 title claims abstract description 34
- FLAQQSHRLBFIEZ-UHFFFAOYSA-N N-Methyl-N-nitroso-4-oxo-4-(3-pyridyl)butyl amine Chemical compound O=NN(C)CCCC(=O)C1=CC=CN=C1 FLAQQSHRLBFIEZ-UHFFFAOYSA-N 0.000 title description 217
- 229920005610 lignin Polymers 0.000 claims abstract description 166
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 7
- 241000196324 Embryophyta Species 0.000 claims description 207
- 230000002829 reductive effect Effects 0.000 claims description 82
- 230000002792 vascular Effects 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 32
- 235000019505 tobacco product Nutrition 0.000 claims description 32
- 239000000945 filler Substances 0.000 claims description 31
- 239000002245 particle Substances 0.000 claims description 28
- 241000208125 Nicotiana Species 0.000 claims description 24
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 21
- 229960002715 nicotine Drugs 0.000 claims description 21
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 21
- 230000009467 reduction Effects 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 238000005096 rolling process Methods 0.000 claims description 14
- 238000005520 cutting process Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 8
- 241001144493 Nicotiana obtusifolia Species 0.000 description 163
- 210000001519 tissue Anatomy 0.000 description 128
- 230000008569 process Effects 0.000 description 25
- 239000002002 slurry Substances 0.000 description 25
- 239000000047 product Substances 0.000 description 21
- 150000004005 nitrosamines Chemical class 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 17
- XKABJYQDMJTNGQ-VIFPVBQESA-N n-nitrosonornicotine Chemical compound O=NN1CCC[C@H]1C1=CC=CN=C1 XKABJYQDMJTNGQ-VIFPVBQESA-N 0.000 description 17
- 239000000443 aerosol Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- -1 NNK Chemical class 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- 238000005266 casting Methods 0.000 description 10
- 238000000605 extraction Methods 0.000 description 10
- 230000000391 smoking effect Effects 0.000 description 10
- 238000010811 Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Methods 0.000 description 9
- 235000019504 cigarettes Nutrition 0.000 description 8
- 238000000227 grinding Methods 0.000 description 8
- 239000002207 metabolite Substances 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 238000007873 sieving Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 238000004108 freeze drying Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000000779 smoke Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229910000831 Steel Inorganic materials 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 229930014251 monolignol Natural products 0.000 description 4
- 125000002293 monolignol group Chemical group 0.000 description 4
- 230000009935 nitrosation Effects 0.000 description 4
- 238000007034 nitrosation reaction Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108010036937 Trans-cinnamate 4-monooxygenase Proteins 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- 231100000315 carcinogenic Toxicity 0.000 description 3
- 230000001055 chewing effect Effects 0.000 description 3
- 235000019506 cigar Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000013618 particulate matter Substances 0.000 description 3
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- CQBQTNMBPLCAHQ-UHFFFAOYSA-N 1,3-dihydroxypentane-1,3,5-tricarboxylic acid Chemical compound OC(=O)C(O)CC(O)(C(O)=O)CCC(O)=O CQBQTNMBPLCAHQ-UHFFFAOYSA-N 0.000 description 2
- ZJOFAFWTOKDIFH-UHFFFAOYSA-N 3-(1-nitroso-3,6-dihydro-2h-pyridin-2-yl)pyridine Chemical compound O=NN1CC=CCC1C1=CC=CN=C1 ZJOFAFWTOKDIFH-UHFFFAOYSA-N 0.000 description 2
- BXYPVKMROLGXJI-JTQLQIEISA-N 3-[(2s)-1-nitrosopiperidin-2-yl]pyridine Chemical compound O=NN1CCCC[C@H]1C1=CC=CN=C1 BXYPVKMROLGXJI-JTQLQIEISA-N 0.000 description 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 2
- 101000762164 Arabidopsis thaliana Cytochrome P450 84A1 Proteins 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 101000984031 Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) Cytochrome P450 monooxygenase lnaD Proteins 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 241001452964 Neottia acuminata Species 0.000 description 2
- 241000493375 Nicotiana quadrivalvis Species 0.000 description 2
- 241001144498 Nicotiana rosulata subsp. ingulba Species 0.000 description 2
- 241000208134 Nicotiana rustica Species 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- 108700023158 Phenylalanine ammonia-lyases Proteins 0.000 description 2
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 2
- 239000001099 ammonium carbonate Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- JMFRWRFFLBVWSI-NSCUHMNNSA-N coniferol Chemical compound COC1=CC(\C=C\CO)=CC=C1O JMFRWRFFLBVWSI-NSCUHMNNSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 238000004807 desolvation Methods 0.000 description 2
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- FLAQQSHRLBFIEZ-MNYIHESISA-N n-methyl-n-[4-oxo-4-(2,4,5,6-tetradeuteriopyridin-3-yl)butyl]nitrous amide Chemical compound [2H]C1=NC([2H])=C(C(=O)CCCN(C)N=O)C([2H])=C1[2H] FLAQQSHRLBFIEZ-MNYIHESISA-N 0.000 description 2
- 229910017464 nitrogen compound Inorganic materials 0.000 description 2
- 150000002830 nitrogen compounds Chemical class 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 2
- 229960001553 phloroglucinol Drugs 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- LZFOPEXOUVTGJS-ONEGZZNKSA-N trans-sinapyl alcohol Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O LZFOPEXOUVTGJS-ONEGZZNKSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000250374 Nicotiana acaulis Species 0.000 description 1
- 244000061322 Nicotiana alata Species 0.000 description 1
- 241000250377 Nicotiana amplexicaulis Species 0.000 description 1
- 241001144490 Nicotiana arentsii Species 0.000 description 1
- 241000250375 Nicotiana benavidesii Species 0.000 description 1
- 241000207746 Nicotiana benthamiana Species 0.000 description 1
- 241000250376 Nicotiana bonariensis Species 0.000 description 1
- 241000250373 Nicotiana cavicola Species 0.000 description 1
- 241001609967 Nicotiana clevelandii Species 0.000 description 1
- 241001244271 Nicotiana cordifolia Species 0.000 description 1
- 241001144496 Nicotiana corymbosa Species 0.000 description 1
- 241000208113 Nicotiana debneyi Species 0.000 description 1
- 241000862464 Nicotiana excelsior Species 0.000 description 1
- 244000006449 Nicotiana forgetiana Species 0.000 description 1
- 241000250367 Nicotiana fragrans Species 0.000 description 1
- 241000208128 Nicotiana glauca Species 0.000 description 1
- 241001495644 Nicotiana glutinosa Species 0.000 description 1
- 241001144503 Nicotiana goodspeedii Species 0.000 description 1
- 241000250366 Nicotiana gossei Species 0.000 description 1
- 241000579278 Nicotiana kawakamii Species 0.000 description 1
- 241000250368 Nicotiana knightiana Species 0.000 description 1
- 241000250019 Nicotiana langsdorffii Species 0.000 description 1
- 241000250027 Nicotiana linearis Species 0.000 description 1
- 241000250024 Nicotiana longiflora Species 0.000 description 1
- 241000250031 Nicotiana megalosiphon Species 0.000 description 1
- 241000250030 Nicotiana miersii Species 0.000 description 1
- 241000250041 Nicotiana noctiflora Species 0.000 description 1
- 241000228665 Nicotiana nudicaulis Species 0.000 description 1
- 241001144488 Nicotiana occidentalis Species 0.000 description 1
- 241001144504 Nicotiana occidentalis subsp. hesperis Species 0.000 description 1
- 241000208132 Nicotiana otophora Species 0.000 description 1
- 241000876839 Nicotiana paniculata Species 0.000 description 1
- 241001144492 Nicotiana pauciflora Species 0.000 description 1
- 241000250042 Nicotiana petunioides Species 0.000 description 1
- 241000208133 Nicotiana plumbaginifolia Species 0.000 description 1
- 241001144487 Nicotiana raimondii Species 0.000 description 1
- 241001290303 Nicotiana repanda Species 0.000 description 1
- 241001144500 Nicotiana rosulata Species 0.000 description 1
- 241001144486 Nicotiana rotundifolia Species 0.000 description 1
- 241001144491 Nicotiana setchellii Species 0.000 description 1
- 241000250044 Nicotiana simulans Species 0.000 description 1
- 241000249970 Nicotiana solanifolia Species 0.000 description 1
- 241001144495 Nicotiana spegazzinii Species 0.000 description 1
- 241000249966 Nicotiana stocktonii Species 0.000 description 1
- 241001144480 Nicotiana suaveolens Species 0.000 description 1
- 241000208136 Nicotiana sylvestris Species 0.000 description 1
- 241001144489 Nicotiana thyrsiflora Species 0.000 description 1
- 241000579280 Nicotiana tomentosa Species 0.000 description 1
- 241000208138 Nicotiana tomentosiformis Species 0.000 description 1
- 241000249968 Nicotiana umbratica Species 0.000 description 1
- 241000228669 Nicotiana velutina Species 0.000 description 1
- 241001144494 Nicotiana wigandioides Species 0.000 description 1
- 108090000913 Nitrate Reductases Proteins 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000592342 Tracheophyta Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- FXXACINHVKSMDR-UHFFFAOYSA-N acetyl bromide Chemical compound CC(Br)=O FXXACINHVKSMDR-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000002419 base digestion Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- LZFOPEXOUVTGJS-UHFFFAOYSA-N cis-sinapyl alcohol Natural products COC1=CC(C=CCO)=CC(OC)=C1O LZFOPEXOUVTGJS-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 229940119526 coniferyl alcohol Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001497 fibrovascular Effects 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 244000038280 herbivores Species 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000012766 organic filler Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 101710093406 p-coumarate 3-hydroxylase Proteins 0.000 description 1
- 229930015763 p-coumaryl alcohol Natural products 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 1
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- PTNLHDGQWUGONS-UHFFFAOYSA-N trans-p-coumaric alcohol Natural products OCC=CC1=CC=C(O)C=C1 PTNLHDGQWUGONS-UHFFFAOYSA-N 0.000 description 1
- PTNLHDGQWUGONS-OWOJBTEDSA-N trans-p-coumaryl alcohol Chemical compound OC\C=C\C1=CC=C(O)C=C1 PTNLHDGQWUGONS-OWOJBTEDSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000005068 transpiration Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000001946 ultra-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/245—Nitrosamines
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B5/00—Stripping tobacco; Treatment of stems or ribs
- A24B5/06—Stripping tobacco; Treatment of stems or ribs by stripping leaf-parts from the stem
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/12—Chemical features of tobacco products or tobacco substitutes of reconstituted tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B3/00—Preparing tobacco in the factory
- A24B3/08—Blending tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B3/00—Preparing tobacco in the factory
- A24B3/12—Steaming, curing, or flavouring tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B3/00—Preparing tobacco in the factory
- A24B3/14—Forming reconstituted tobacco products, e.g. wrapper materials, sheets, imitation leaves, rods, cakes; Forms of such products
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B7/00—Cutting tobacco
Definitions
- the present invention relates, in general, to methods for reducing the amount of nicotine-derived nitrosamine ketone or 4-(methylnitrosamino)-1 -(3-pyridyl)-1 -butanone (NNK) in tobacco plant material.
- Nitrosamines are organic compounds found in many consumer products - such as tobacco, food products and cosmetics. Nitrosamines have drawn intense scientific interest because some of the compounds in this class have been shown to be carcinogenic in laboratory animals. It has been reported that some cured tobaccos contain tobacco specific nitrosamines that can be found in smokeless tobacco, mainstream smoke and side stream smoke of cigarettes. In tobacco, at least four species of nitrosamines are produced at appreciable quantity.
- tobacco specific nitrosamines are not considered to be present in significant quantities in growing tobacco plants or fresh cut tobacco (green tobacco), but are formed during the tobacco curing process. In addition to the formation of tobacco specific nitrosamines during the curing process of green leaves, tobacco specific nitrosamines may also be formed during processes used to prepare aqueous tobacco slurries - such as processes used to prepare reconstituted tobacco.
- NNK nitrosamines in air-cured tobacco
- Matrix-bound NNK can be extracted with a 0.1 N KOH solution from water-washed Burley filler.
- This alkaline treatment also decreases NNK levels in smoke (Keene, C.K., 1992, The Effect of Base Digestion on TSNA in Extractables-Depleted Fillers. Legacy Tobacco Documents).
- the treatment can introduce toxicologically relevant compounds into tobacco and can significantly deteriorate the quality of the tobacco, which is highly problematic for the tobacco industry.
- WO2010/021809 describes a method for recuing nitrogen compounds and lignin in tobacco. Nitrogen compounds are removed by solvent extraction; lignin is removed in a separate step.
- a cost-effective and simple method for reducing the levels of matrix-bound NNK in cured tobacco that does not introduce toxic or potentially toxic compounds and does not deteriorate the quality of the tobacco product is particularly desirable.
- the present invention is based, at least in part, on the surprising finding that matrix-bound NNK co- localises with lignin in tobacco plants.
- the present inventors have observed that within cured parts of a tobacco plant - such as in the stems and midribs - matrix-bound NNK co- localises or co-localises predominantly or co-localises exclusively with lignin - such as lignified tissue, particularly in the vascular bundle (for example, the xylem) and not the surrounding tissues - such as the cortex. Therefore removal of lignin (for example, by separating lignified from non- lignified tissue) can reduce the amount of matrix-bound NNK and metabolites thereof in plant material.
- Matrix-bound NNK can be covalently or non-covalently linked to lignin.
- the plant material is expected to deliver smoke with reduced NNK levels and potentially improved sensory properties.
- the present disclosure can be applied to those plant materials which accumulate matrix-bound NNK or have the potential to accumulate matrix-bound NNK.
- the disclosure can be applied to low-value plant material comprising matrix-bound NNK that is used in certain tobacco processes.
- the methods described herein can be carried out without the use of any additives and thereby do not introduce additional toxicologically relevant compounds into the plant material.
- the removal of lignin can take place during or after curing of tobacco plant material. Lignin can be removed before curing to prevent, reduce or inhibit matrix-bound NNK co-localising with lignin.
- One general object of this disclosure is to substantially decrease the amount of matrix-bound NNK and metabolites thereof in tobacco intended for smoking or consumption by other means. Another general object is to reduce the carcinogenic potential of tobacco products, including cigarettes, cigars, chewing tobacco, snuff and tobacco-containing gum and lozenges. Still another general object is to decrease or reduce the amount of matrix-bound NNK and metabolites thereof in tobacco plant material and in tobacco products. Another general object is to reduce the amount of matrix-bound NNK and metabolites thereof in cured - such as partially or fully cured - tobacco plant material. Another general object is to reduce the amount of NNK and metabolites thereof in aerosol, including smoke.
- Yet another object of this disclosure is to reduce the amount of NNK or metabolites thereof in humans who smoke, consume or otherwise ingest tobacco in some form, by providing a tobacco product suitable for human consumption which contains a reduced amount of NNK or metabolites thereof, thereby lowering the carcinogenic potential of such product.
- a method of reducing the amount of matrix-bound NNK in a cured tobacco plant or in cured tobacco plant material comprising reducing the amount of lignin therein by separating lignified from non-lignified tissue, preferably, wherein the amount of lignin is reduced chemically and/or mechanically.
- the tobacco plant or the tobacco plant material is treated to expand non- lignified plant tissue.
- the amount of lignified tissue is reduced by separating the expanded and non-expanded plant tissue based on their different densities (for example, buoyant densities) and/or their different strengths and/or their different sizes and/or their different weight.
- the expanded plant tissue can be collected for further tobacco processing.
- NNK and associated TSNAs have been observed that significant reduction in levels of NNK and associated TSNAs can be obtained by fractionating the lignified tissues. Separate chemical extraction of nitrogenous compounds and/or lignin is not necessary.
- the amount of lignin is reduced by removing the vascular bundle or xylem or lignified sclerenchymatic tissue or a combination of two or more thereof from the plant or plant material.
- the lignin can be located in the vascular bundle.
- the lignin can be located exclusively in the vascular bundle.
- the lignin can be located exclusively in the vascular bundle and not the surrounding tissue.
- the lignin can be located in the xylem.
- the lignin can be located exclusively in the xylem.
- the lignin can be located exclusively in the xylem and not the surrounding tissue.
- the lignin can be located in sclerenchymatic tissue.
- the lignin can be located exclusively in sclerenchymatic tissue.
- the lignin can be located exclusively in the sclerenchymatic tissue and not the surrounding tissue.
- Lignified tissue is generally absent from the outer layer of plant midribs.
- the plant or plant material that is treated according to the present disclosure comprises or consists or consists essentially of plant midribs or plant stems or plant stalks or a combination of two or more thereof.
- the amount of lignin is reduced by harvesting the cortex - such as the outer cortex - from the plant or plant material.
- the method comprises the steps of: (a) providing a cured tobacco plant or cured tobacco plant material; (b) reducing the amount of lignin in the cured tobacco plant or the cured tobacco plant material by fractionating the tobacco plant material; and (c) obtaining a cured tobacco plant or cured tobacco plant material in which the amount of lignin is reduced and the amount of matrix-bound NNK is reduced as compared to the cured tobacco plant or the cured tobacco plant material provided in step (a).
- step (a) there is a further step of measuring the amount of free NNK or matrix-bound NNK or a combination thereof, and optionally, wherein following step (b) there is a further step of measuring the amount of free NNK or matrix-bound NNK or a combination thereof.
- the method comprises the further step (d) of comparing the level of at least matrix-bound NNK measured following step (a) with the level of NNK measured following step (b), wherein a reduction in the amount of matrix-bound NNK in the tobacco material obtained in step (b) as compared to the tobacco material provided in step (a) is indicative that the amount of matrix- bound NNK in the tobacco material is reduced.
- a method of reducing the formation of matrix-bound NNK during the curing of a tobacco plant or tobacco plant material comprising reducing the amount of lignin therein prior to curing.
- the method comprises the steps of: (a) providing an uncured tobacco plant or uncured tobacco plant material; (b) reducing the amount of lignin in the uncured tobacco plant or the uncured tobacco plant material prior to curing; (c) curing the tobacco plant or the tobacco plant material provided in step (b); and (d) obtaining a cured tobacco plant or cured tobacco plant material in which the amount of matrix-bound NNK is reduced as compared to a control in which the amount of lignin has not been reduced.
- step (a) there is a further step of measuring the amount of free NNK or matrix-bound NNK or a combination thereof, and optionally, wherein following step (b) there is a further step of measuring the amount of free NNK or matrix-bound NNK or a combination thereof and optionally, wherein following step (c) there is a further step of measuring the amount of free NNK or matrix-bound NNK or a combination thereof.
- step (c) or step (d) said method comprises the further step of comparing the level of at least matrix-bound NNK measured following step (a) with the level of NNK measured following step (b) and/or step (c), wherein a reduction in the amount of matrix-bound NNK in the tobacco material obtained in step (b) or step (c) as compared to the tobacco material provided in step (a) is indicative that the amount of matrix-bound NNK in the tobacco material is reduced.
- tobacco plant material obtained or obtainable by the method(s) described herein.
- a tobacco plant or tobacco plant material in which the amount of lignin therein has been reduced as compared to control tobacco plant or control tobacco plant material for manufacturing tobacco with reduced levels of matrix-bound NNK, wherein said levels of matrix-bound NNK are reduced as compared to the control.
- a method for producing reconstituted tobacco comprising the steps of: (a) performing the method(s) described herein; (b) manufacturing the tobacco material obtained in step (a) into reconstituted tobacco; and (c) optionally incorporating the reconstituted tobacco into a tobacco product.
- a method for preparing tobacco for use as a tobacco cut filler comprising the steps of: (a) performing the method(s) described herein; and (b) rolling and cutting the tobacco material for use as a tobacco cut filler.
- cured tobacco plant material containing a reduced level of lignin as compared to control tobacco plant material in which the amount of lignin has not been reduced, and wherein the amount of matrix-bound NNK is about 3500 ng/g or less.
- the average particle size is greater than about 0.5 millimetres.
- the amount of free NNK is less than about 330 ng/g, optionally wherein the
- NNN content is less than about 1700 ng/g and optionally wherein the nicotine content is less than about 2610 pg/g.
- the cured tobacco plant material comprises, consists of consists essentially of plant cortex - such as outer plant cortex.
- vascular bundle or xylem or lignified sclerenchymatic tissue or a combination of two or more thereof is substantially absent from the cured tobacco plant material.
- the cured tobacco plant material comprises, consists of consists essentially of plant cortex - such as outer plant cortex - and vascular bundle or xylem or lignified sclerenchymatic tissue or a combination of two or more thereof is substantially absent therefrom.
- the cured tobacco plant material is obtained or obtainable from plant midribs or plant stems or plant stalks or a combination of two or more thereof.
- the average particle size is greater than about 0.5 millimetres.
- the amount of free NNK is less than about 330 ng/g.
- the NNN content is less than about 1700 ng/g.
- the nicotine content is less than about 2610 ⁇ g/g.
- a tobacco product or a reconstituted tobacco product comprising, consisting or consisting essentially of the plant material or the cured plant material described herein.
- a method of producing an aerosol in which the amount of NNK is reduced as compared to a control aerosol comprising the steps of: (a) providing a cured tobacco plant or cured tobacco plant material; (b) reducing the amount of lignin in the cured tobacco plant or the cured tobacco plant material; (c) obtaining a cured tobacco plant or cured tobacco plant material in which the amount of lignin is reduced and the amount of matrix-bound NNK is reduced as compared to the cured tobacco plant or the cured tobacco plant material provided in step (a); and (d) heating the cured tobacco plant or cured tobacco plant material from step (c) to produce an aerosol.
- a method of producing an aerosol in which the amount of NNK is reduced as compared to a control aerosol comprising the steps of: (a) providing an uncured tobacco plant or uncured tobacco plant material; (b) reducing the amount of lignin in the uncured tobacco plant or the uncured tobacco plant material prior to curing; (c) curing the tobacco plant or the tobacco plant material provided in step (b); (d) obtaining a cured tobacco plant or cured tobacco plant material in which the amount of matrix-bound NNK is reduced as compared to a control in which the amount of lignin has not been reduced; and (e) heating the cured tobacco plant or cured tobacco plant material from step (d) to produce an aerosol.
- a method of producing an aerosol in which the amount of NNK is reduced as compared to a control aerosol comprising the step of: (a) providing a tobacco product or a reconstituted tobacco product comprising, consisting or consisting essentially of the tobacco plant material or the cured plant material obtained or obtainable by the methods described herein; and (b) heating the tobacco product or the reconstituted tobacco product to produce an aerosol.
- an aerosol obtained or obtainable by the method(s) described herein.
- cured tobacco plant material consisting essentially of tobacco plant cortex and wherein the amount of matrix-bound NNK is reduced as described herein.
- a method for blending tobacco in which at least two different types of tobacco are blended so as to form a tobacco blend comprising the steps of: (a) providing a first cured tobacco plant material and reducing the amount of lignin therein; (b) measuring the total and/or matrix-bound NNK content of the first cured tobacco plant material and selecting cured tobacco plant material in which the total and/or matrix-bound NNK content is reduced as compared to the first cured tobacco plant material provided in step (a); (c) providing a second cured tobacco plant material which has a higher total and/or matrix-bound NNK content than the total and/or matrix-bound NNK of the first cured tobacco plant material obtained in step (b), and optionally measuring the total and/or matrix-bound NNK content in the second cured tobacco plant material; (d) blending together the first and second cured tobacco plant materials from steps (b) and (c) and optionally measuring the total and/or matrix-bound NNK content in the blended tobacco plant material; and (e)
- Figure 1 is a graph illustrating the distribution of free NNK, matrix-bound NNK and lignin in lignified (L) and non-lignified (NL) tissues in cured Burley midribs or cured Burley stems.
- Figure 2 is a cross-section of a hydrated cured Burley stem showing lignified (L) and non-lignified (NL) tissues. Lignified tissue is stained red with phloroglucinol.
- Figure 3 is a graph illustrating the distribution of free NNK, matrix-bound NNK and lignin in lignified (L) and non-lignified (NL) tissues of green Burley midribs after nitrosation with sodium nitrite solution (1 .5 mL (10 mg/mL in water) for 4 hours at room temperature with shaking).
- Figure 4 is a graph illustrating free and matrix-bound NNK in sieving fractions of ground freeze- dried Burley tobacco plant stems.
- Figure 5 is graph showing the correlation between matrix-bound NNK and lignin in sieving fractions of ground freeze-dried Burley tobacco plant stems.
- Figure 6 is a graph showing the concentration of matrix-bound NNK ⁇ g/g) in sclerenchymatic tissue (S) and in the outer layers of the midribs (NS) after nitrosation and washing in green midribs of TN90. Levels of pseudo-oxynictoine (PON) ⁇ g/g) and nicotine ⁇ g/g) are also shown. Matrix- bound NNK levels (ng/g) in lignified (CS) and non-lignified (CNS) parts of a commercial cured Burley stem sample are also shown. Levels of NNN (ng/g) and nicotine ⁇ g/g) are also shown.
- PON pseudo-oxynictoine
- CS lignified
- CNS non-lignified
- the term “plant” refers to any plant or any part thereof at any stage of its life cycle or development, and its progenies.
- the plant is a tobacco plant, which refers to a plant belonging to the genus Nicotiana. Preferred species of tobacco plant are described herein.
- a "plant cell” refers to a structural and physiological unit of a plant.
- the plant cell may be in the form of a protoplast without a cell wall, an isolated single cell or a cultured cell, or as a part of higher organized unit such as but not limited to, plant tissue, a plant organ, or a whole plant.
- the plant cell is a tobacco plant cell.
- plant material refers to any part of a plant or a mixture of different parts of plant or a mixture of different plants and includes without limitation plant tissues, leaf scraps, green leaf scraps, stems, dust created during plant processing, and leaf prime lamina strip and combinations thereof.
- the plant material will comprise, consist or consist essentially of a plant part or a mixture of plant parts containing lignin - such as plant midribs or plant stems or plant stalks or a combination or two or more thereof.
- Tobacco plant material can have the form of processed tobacco parts or pieces, uncured, cured or aged tobacco in essentially natural lamina or stem form, a tobacco extract or a mixture of the foregoing, for example, a mixture that combines extracted tobacco pulp with granulated cured and aged natural tobacco lamina.
- the plant material can be in solid form, in liquid form, in semi-solid form, in ground form, in crushed form, in sieved form, or in particulate form or the like or otherwise treated to reduce particle size.
- the plant material can be in the form of a homogenate that has been subjected to homogenization, including, but not limited to cutting or grinding or a combination thereof.
- the homogenate may be prepared from whole plants or from mixtures of plant components - such as a mixture of plant parts containing lignin, for example, midribs or stems or stalks or a combination of two or more thereof - that have been subjected to homogenisation.
- the plant material can be in the form of a slurry, including a suspension of plant material or a plant homogenate in an aqueous solution or solvent.
- the slurry can be a 5% (w/v), 10% (w/v), 15% (w/v), 20% (w/v) or 25% (w/v) or more mixture of plant material in an aqueous solution or solvent.
- the plant material is that plant material which comprises, consists or consists essentially of lignin - such as lignified tissue. In one embodiment, the plant material is that plant material which comprises, consists or consists essentially of the vascular bundle. In one embodiment, the plant material is that plant material which comprises, consists or consists essentially of xylem. In one embodiment, the plant material is that plant material which comprises, consists or consists essentially of lignified sclerenchymatic tissue. In one embodiment, the plant material comprises, consists or consists essentially of plant midribs or plant stems or plant stalks or a combination of two or more thereof. In one embodiment, the plant material is tobacco plant material.
- tobacco product includes smoking or smokable articles, and smokeless tobacco products.
- free NNK refers to the NNK concentration calculated from the NNK content of extracts prepared by extracting said plant material with aqueous buffer(s) at room temperature. The free NNK content in such extracts can be determined using ultra performance liquid chromatography- tandem mass spectrometry (UPLC-MS/MS).
- total NNK refers to the NNK concentration calculated after subjecting the extraction mixtures to the methods described herein (for example, by heating to about 130°C for about 4 hours) and filtering aliquots of the extracts.
- the total NNK content in such extracts can be determined using UPLC-MS/MS.
- bound NNK or "matrix-bound NNK” as used herein represents the difference between the “total NNK” and the “free NNK” concentration.
- reduced lignin content or “decreased lignin content” or “non-lignified” grammatical variations thereof refers to a measurable quantitative reduction in the amount of lignin in a plant when compared to the amount of lignin in a comparable control plant.
- a quantitative reduction of lignin can be readily ascertained by assays that are known in the art and include the Klason lignin assay (Method in Enzymol., 161 :87-101 (1988)), the acetyl bromide assay ⁇ Wood Sci. Techno!., 22:271 -280 1988)) or the photometric method based on derivatisation with thioglycolic acid (J.
- non-lignified tissue the amount of lignin is decreased as compared to a comparable control plant and the amount of lignin can be completely, substantially or partially removed.
- a detectable amount of lignin can be present provided that there is a measurable quantitative reduction in the amount of lignin when compared to a comparable control plant in which the amount of lignin has not been reduced.
- Non-lignified tissue it may not be possible to detect any amount of lignin.
- Non-lignified tissue can contain less than 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2% or 1 % of the total dry weight content of lignin in the plant or plant part from which it is removed.
- control plant refers to a plant or a plant cell - such as a native or naturally occurring plant or plant cell - having a lignin content and/or a NNK content that has not been manipulated or modified.
- Control plant material includes plant material obtained from, derived from or derivable from the control plant or the control plant cell or a combination thereof.
- the control plant or control plant cell can be the same type of plant or plant cell, for example, the same species of plant or plant cell as the plant or plant cell that it is being compared to.
- the control plant or control plant cell may correspond to a wild-type plant or wild-type plant cell.
- reduce or “decrease” or grammatical variations thereof refers to a reduction of from about 10% to about 99%, or a reduction of at least 10%, at least 20%, at least 25%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 75%, at least 80%, at least 90%, at least 95%, at least 98%, at least 99%, or at least 100% or more of a quantity, amount or activity.
- inhibitor or grammatical variations thereof, refers to a reduction of from about 98% to about 100%, or a reduction of at least 98%, at least 99%, but particularly of 100%, of a quantity, amount or activity.
- the term "increase” or grammatical variations thereof refers to an increase of from about 5% to about 99%, or an increase of at least 5%, at least 10%, at least 20%, at least 25%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 75%, at least 80%, at least 90%, at least 95%, at least 98%, at least 99%, or at least 100% or more of a quantity, amount or activity.
- the term "about” in the context of a given numerate value or range refers to a value or range that is within 20 %, within 10 %, or within 5 % of the given value or range.
- At least a portion or grammatical variations thereof includes at least about 5%, at least about 10 %, at least about 20%, at least about 30%, at least about 40%, at least about 50 %, at least about 60%, at least about 70%, at least about 75%, at least about 80%, at least about 90%, at least about 95%, at least about 98%, or at least about 99% of a quantity, amount or activity.
- the present disclosure can be applied to any form of tobacco plant material in which NNK or metabolites thereof or a combination thereof can form or have formed.
- at least a portion of the NNK is in the bound form.
- At least a portion of the matrix-bound form co- localises with lignin - such as lignified tissue.
- Methods for measuring free nitrosamine(s) and matrix-bound nitrosamine(s) are well known in the art and described herein. Briefly, aliquots of tobacco samples can be extracted and the nitrosamine content therein can be analysed using ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).
- one or more standards corresponding to the one or more nitrosamines that are being quantified will be incorporated into the aliquots of the tobacco samples.
- the sample concentration calculated from the extract corresponds to the "free nitrosamine(s)" concentration in the sample.
- nitrosamine concentrations can again be measured by UPLC-MS/MS. From these values, the “total NNK” concentration in the samples can be calculated.
- the “matrix-bound NNK” concentration is the difference between the “total NNK” and the "free NNK” concentration.
- Green tobacco Freshly harvested tobacco leaves are referred to as "green tobacco” and are believed to contain no nitrosamines, but green tobacco is not suitable for human consumption.
- the process of curing green tobacco depends on the type of tobacco harvested. For example, Virginia flue (bright) tobacco is typically flue-cured, whereas Burley and certain dark strains are usually air-cured.
- the flue-curing of tobacco typically takes place over a period of five to seven days compared to one to two months for air-curing. Many major chemical and biochemical changes occur during the curing process and continue through the early phases of leaf drying.
- nitrosamines including NNK
- NNK nitrosamines
- the exact mechanism by which tobacco-specific nitrosamines, including NNK, are formed is not clear, but is believed to be enhanced by microbial activity, involving microbial nitrate reductases in the generation of nitrite during the curing process.
- Lignin is the generic term for a large group of aromatic polymers resulting from the oxidative combinatorial coupling of 4-hydroxyphenylpropanoids. These polymers are deposited predominantly in the walls of secondarily thickened cells - such as fibers and tracheary elements - making them rigid and impervious. The mechanical rigidity of lignin strengthens these tissues so that the tracheary elements can endure the negative pressure generated from transpiration without collapse of the tissue. In addition to providing mechanical strength, lignin has protective functions. For example, the physical toughness and chemical durability of lignin may deter feeding by herbivores.
- Lignification is a frequent response to infection or wounding, which may provide a physical barrier to block the penetration of pathogens.
- the main building blocks of lignin are the hydroxycinnamyl alcohols (or monolignols) coniferyl alcohol and sinapyl alcohol, with typically minor amounts of p-coumaryl alcohol.
- the monolignols are synthesized from Phe through the general phenylpropanoid and monolignol-specific pathways. Phe is derived from the shikimate biosynthetic pathway in the plastid.
- Certain enzymes of the lignin biosynthetic pathway namely the cytochrome P450 enzymes cinnamate 4-hydroxylase (C4H), p- coumarate 3-hydroxylase (C3H), and ferulate 5-hydroxylase (F5H), are membrane proteins thought to be active at the cytosolic side of the endoplasmic reticulum.
- metabolic channeling has been shown between phenylalanine ammonia-lyase (PAL) and C4H, it remains unknown whether the other pathway enzymes are also part of metabolic complexes at the endoplasmic reticulum.
- the units resulting from the monolignols, when incorporated into the lignin polymer are called guaiacyl (G), syringyl (S), and p-hydroxyphenyl (H) units.
- Lignin is commonly found in, for example, plant midribs, plant stems or plant stalks.
- the material for use in the present disclosure can include plant midribs or plant stems or plant stalks or a mixture thereof or a combination of two or more thereof and can be removed.
- Lignin is located in, for example, the vascular bundle of a tobacco plant which can be found in plant midribs, plant stems, plant stalks and the like.
- the vascular bundle is composed of a plurality of relatively hard, cellulose members closely secured together by fibrous vegetable connecting tissue.
- Surrounding this fibro-vascular bundle is the cortex which is formed of a relatively sponge-like vegetable tissue or covering constituting the larger portion of the stem and the portion which is closer in characteristics and properties to the lamina of the tobacco leaf.
- Lignin is generally located in the vascular bundle.
- the vascular bundle is a part of the transport system in vascular plants.
- the transport itself happens in vascular tissue, which exists in two forms, the xylem and phloem. Both these tissues are present in a vascular bundle, which in addition will include supporting and protective tissues. Of these vascular tissues, lignin is to be found only in the xylem.
- the amount of lignin can be substantially reduced in plant midribs, plant stems or plant stalks and the like or a mixture or a combination of two or more thereof.
- Lignin can be substantially removed from plant midribs, plant stems or plant stalks and the like or a mixture or a combination of two or more thereof.
- the vascular bundle or the xylem or a combination thereof is substantially reduced in plant midribs, plant stems or plant stalks and the like or a mixture or a combination of two or more thereof.
- the vascular bundle or the xylem or a combination thereof is substantially removed from plant midribs, plant stems or plant stalks and the like or a mixture or a combination of two or more thereof.
- lignified sclerenchymatic tissue is substantially removed from plant midribs, plant stems or plant stalks and the like or a mixture or a combination of two or more thereof.
- the amount of lignin is reduced by separating lignified from non-lignified tissue.
- the outer cortex can be readily separated from the vascular bundle containing lignin, thus obtaining plant material with reduced levels of lignin.
- the plant material containing reduced levels of lignin or substantially no lignin can be used in the manufacture of tobacco materials or tobacco products with reduced levels of matrix-bound NNK as described herein.
- the separated plant material containing lignin co-localised with matrix-bound NNK can be discarded or used in other processes.
- a method of reducing or decreasing the amount of matrix-bound NNK in a cured tobacco plant or in cured tobacco plant material comprising reducing the amount of lignin therein.
- a cured tobacco plant or cured tobacco plant material is provided.
- the amount of lignin in the cured tobacco plant or the cured tobacco plant material is reduced.
- the lignin can be completely removed or partially removed.
- a cured tobacco plant or cured tobacco plant material is then obtained in which the amount of lignin is reduced and the amount of matrix-bound NNK is also reduced as compared to the cured tobacco plant or the cured tobacco plant material initially provided or as compared to a control.
- the lignin to be completely or partially removed can be located in the vascular bundle.
- the lignin to be completely or partially removed can be located exclusively in the vascular bundle.
- the lignin to be completely or partially removed can be located exclusively in the vascular bundle and not the surrounding tissue.
- the lignin to be completely or partially removed can be located in the xylem.
- the lignin to be completely or partially removed can be located exclusively in the xylem.
- the lignin to be completely or partially removed can be located exclusively in the xylem and not the surrounding tissue.
- the lignin to be completely or partially removed can be located in lignified sclerenchymatic tissue.
- the lignin to be completely or partially removed can be located exclusively in lignified sclerenchymatic tissue.
- the lignin to be completely or partially removed can be located exclusively in the lignified sclerenchymatic tissue and not the surrounding tissue - such as the outer layer of midribs.
- the amount of matrix-bound NNK in a cured tobacco plant or in cured tobacco plant material is reduced by reducing the amount of the lignified sclerenchymatic tissue in the cured tobacco plant or in the cured tobacco plant material.
- a method of reducing, decreasing, preventing or inhibiting the formation of matrix-bound NNK during the curing of a tobacco plant or tobacco plant material comprising reducing the amount of lignin therein prior to curing.
- the tobacco plant or tobacco plant material can be uncured or substantially uncured.
- the method can be used to reduce, decrease, prevent or inhibit the co-localisation of NNK with lignin that would otherwise occur during the subsequent curing process.
- an uncured tobacco plant or uncured tobacco plant material or substantially uncured tobacco plant or substantially uncured tobacco plant material is provided and the amount of lignin therein is reduced prior to curing or during curing.
- the lignin can be completely removed or partially removed.
- the lignin can be located in the vascular bundle.
- the lignin can be located exclusively in the vascular bundle.
- the lignin can be located exclusively in the vascular bundle and not the surrounding tissue.
- the vascular bundle can be completely removed or partially removed.
- the lignin can be located in the xylem.
- the lignin can be located exclusively in the xylem.
- the lignin can be located exclusively in the xylem and not the surrounding tissue.
- the xylem can be completely removed or partially removed.
- the lignin can be located in the lignified sclerenchymatic tissue.
- the lignin can be located exclusively in the lignified sclerenchymatic tissue.
- the lignin can be located exclusively in the lignified sclerenchymatic tissue and not the surrounding tissue - such as the outer layer of midribs. Thus, the lignified sclerenchymatic tissue can be completely removed or partially removed. The lignin can be completely removed or partially removed. After subjecting the tobacco plant or the tobacco plant material to curing, using methods that are well known in the art, a cured tobacco plant or cured tobacco plant material in which the amount of matrix-bound NNK and the amount of lignin is reduced as compared to the starting material or as compared to a control can be obtained.
- the amount of lignin in a tobacco plant or in tobacco plant material can be reduced using various methods that are well known in the art.
- a batch of stems or the like can be moistened or soaked in fluid, for example, water, which causes the cortex to soften and expand or swell whilst leaving the lignin in an unexpanded state.
- the cortex can be removed manually (eg. by hand) and retained and the vascular bundle containing lignin can be discarded or used elsewhere. Accordingly, the cortex (for example, the outer cortex) can be separated from lignified tissue and retained and the unexpanded lignified tissue discarded. The cortex can then be used for further tobacco processing.
- non-lignified plant tissue can be expanded in order to separate lignified and non-lignified tissue.
- the non-lignified tissue is selectively or preferentially expanded over the lignified tissue.
- lignin can be separated using suitable decorticating machinery.
- a decorticator is a machine for stripping the bark, wood and plant stalks and the like.
- mechanical separation can be used.
- soaking of the batch of stems or the like is followed by freeze drying.
- soaking of the batch of stems or the like is followed by freeze drying, grinding and sieving.
- tobacco plant material can be ground into a powder form using equipment and techniques for grinding, milling, or the like.
- the tobacco plant material is relatively dry in form during grinding or milling, using various equipment - such as hammer mills, cutter heads, air control mills and the like.
- the plant material can be reduced in size to form particles or particulate matter using various methods that are known in the art.
- the particles or particulate matter can be separated by size to obtain fractions with reduced levels of lignin and reduced levels of matrix-bound NNK.
- plant material is treated by impact - such as by impact with one or more objects that are harder than the plant material to be treated.
- impact with metal - such as metal balls - is used.
- the impact can be delivered using various methods, such as shaking.
- plant material can be impacted with steel balls (2 steel balls, diameter 2 cm) with shaking at 300 rpm for 15 minutes.
- the particles or particulate matter can be separated by size using a sieve shaker into fractions of different particle size(s).
- the average particle is greater than about 0.5 millimetres, greater than about 0.85 millimetres or greater than about 1 millimetre.
- the plant material can be ground or milled when the moisture content thereof is less than about 15 weight percent to less than about 5 weight percent.
- the tobacco plant material can be finely ground. Finely ground tobacco material typically has a particle size of from about 30 to 600 microns.
- the method comprises expansion, for example by contacting with a fluid (eg. by water soaking), followed by freeze drying, which will result in the expansion of plant material - which does not contain lignin or contains only low levels of lignin. Lignified plant material will retain a higher density, higher physical strength and a smaller particle size than the expanded plant tissue thereby permitting separation by size.
- the method comprises expansion, followed by freeze drying, followed by grinding (for example, by impact as discussed above), followed by sorting (for example, sorting by size) of the resulting fragments and selection of the fragments with reduced levels of lignin and reduced levels of matrix-bound NNK. Sieving may be used for this purpose.
- the method comprises expansion, followed by grinding or crushing or a combination thereof, (for example, by impact, as described above), followed by sorting by size (using sieving or based upon density and/or mechanical strength, for example)the resulting particles and selection of the particles with reduced levels of lignin and reduced levels of matrix-bound NNK.
- the different sized fractions may also differ in their free-NNK content or their NNN content or their nicotine content or a combination of two of more thereof.
- the plant material can optionally be further processed for use in a tobacco product.
- this material can be formed into an aqueous slurry.
- the resulting slurry can contain a substantial proportion of colloidal cortex particles dispersed therein.
- the conversion of the tobacco cortex into an aqueous slurry can be accomplished using a suitable type of mill - such as a ball mill or a colloid mill. The further processing of the cortex and aqueous slurry is described herein.
- the plant material obtained or obtainable by the methods described herein comprises, consists or consists essentially of tissue surrounding the vascular bundle or the tissue surrounding the xylem or the tissue surrounding the lignified sclerenchymatic tissue or a combination of two or more thereof with the vascular bundle or the xylem or the lignified sclerenchymatic tissue or a combination of two or more thereof substantially absent.
- the plant material comprises, consists or consists essentially of the tissue surrounding the vascular bundle or the xylem or lignified sclerenchymatic tissue or a combination of two or more thereof and substantially no vascular bundle or no xylem or no lignified sclerenchymatic tissue or a combination of two or more thereof. In certain embodiments, the plant material comprises, consists or consists essentially of the tissue surrounding the vascular bundle or the xylem or the lignified sclerenchymatic tissue or a combination of two or more thereof and no vascular bundle or no xylem or no lignified sclerenchymatic tissue or a combination of two or more thereof. In certain embodiments, the plant material comprises, consists or consists essentially of the outer tobacco cortex. In certain embodiments, the plant material comprises, consists or consists essentially of the outer layers of plant midribs.
- the methods described herein may comprise one or more further steps of measuring and optionally comparing the levels of free NNK or matrix-bound NNK or a combination thereof.
- Methods for measuring free NNK and matrix-bound NNK are described herein.
- the amount of free NNK or matrix-bound NNK or a combination thereof is determined in a cured tobacco plant or in cured tobacco plant material. After reducing the amount of lignin in the cured tobacco plant or the cured tobacco plant material the amount of free NNK or matrix- bound NNK or a combination thereof can be measured again.
- the level of at least matrix-bound NNK can be compared with the initial starting material to ascertain if the level of matrix-bound NNK has been reduced.
- the level of at least matrix-bound NNK previously measured can be compared with the level of NNK measured following the reduction of the amount of lignin.
- a reduction in the amount of matrix-bound NNK in the tobacco material obtained following the reduction of the amount of lignin as compared to the tobacco material initially provided is indicative that the amount of matrix-bound NNK has been reduced.
- the methods described herein may comprise one or more further steps of measuring and optionally comparing the levels of free NNK or matrix-bound NNK or combinations thereof.
- the amount of free NNK or matrix-bound NNK or a combination thereof is measured in the uncured tobacco plant or uncured tobacco plant material.
- the method may include one or more comparison steps.
- the method may comprise the further step of comparing the level of at least matrix-bound NNK initially measured, as discussed above, with the level of NNK later measured, wherein a reduction in the amount of matrix-bound NNK in the tobacco material as compared to the tobacco material initially provided is indicative that the amount of matrix-bound NNK in the tobacco material is reduced.
- Free NNK or matrix-bound NNK or a combination thereof can be measured at the start of the method and/or at the end of the method and/or during the method. Free NNK or matrix-bound NNK or a combination thereof may be measured intermittently or at intervals. The intervals may be fixed intervals or random intervals. Free NNK or matrix-bound NNK or a combination thereof can measured at the end of the method to check that the free NNK or matrix-bound NNK or a combination thereof is present within a desired amount, concentration or range.
- Lignin can be covalently or non-covalently bound to lignin.
- a complex comprising lignin covalently or non-covalently bound to NNK is described.
- a plant cell, plant tissue or plant or plant material comprising the complex is also disclosed.
- a method for reducing the amount of matrix-bound NNK in a cured tobacco plant or in cured tobacco plant material is also described comprising reducing the amount of the complex therein.
- the amount of matrix-bound NNK can be about 3000 ng/g or less, about 2500 ng/g or less, about 2000 ng/g or less, about 2000 ng/g or less, about 1500 ng/g or less, about 1000 ng/g or less or about 500 ng/g or less.
- the average particle size of this cured plant tissue can be greater than about 0.5 millimetres, greater than about 0.85 millimetres or greater than about 1 millimetre.
- the amount of free NNK in this cured plant tissue can be about 330 ng/g or less, about 300 ng/g or less, about 250 ng/g or less, about 200 ng/g or less, about 150 ng/g or less, about 100 ng/g or less or about 50 ng/g or less.
- the amount of NNN in this cured plant tissue can be about 1700 ng/g or less, about 1500 ng/g or less, about 1300 ng/g or less, about 1 100 ng/g or less, about 1000 ng/g or less, or about 500 ng/g or less.
- the amount of nicotine in this cured plant tissue can be about 2600 ⁇ g or less, about 2300 ⁇ g or less or about 2100 ⁇ g or less.
- the amount of lignin in this cured plant tissue can be about 6.5 % or less of the total dry weight content of the cured plant tissue, about 6 % of the total dry weight content of the cured plant tissue, about 5 % of the total dry weight content of the cured plant tissue, about 4 % of the total dry weight content of the cured plant tissue or about 3 % of the total dry weight content of the cured plant tissue.
- cured plant tissue containing a reduced level of lignin as compared to control plant tissue in which the amount of lignin has not been reduced, and wherein the amount of matrix-bound NNK is about 3500 ng/g or less and the average particle size is about 0.5 mm or greater.
- the amount of free NNK is about 300 ng/g or less.
- the amount of NNN is about 1700 ng/g or less.
- the amount of lignin in this cured plant tissue is about 6.4 % or less of the total dry weight content of the cured plant tissue.
- the amount of nicotine is about 2600 ⁇ g or less.
- cured plant tissue containing a reduced level of lignin as compared to control plant tissue in which the amount of lignin has not been reduced, and wherein the amount of matrix-bound NNK is about 1900 ng/g or less and the average particle size is between about 0.85 mm and about 1 mm.
- the amount of free NNK is about 250 ng/g or less.
- the amount of NNN is about 1270 ng/g or less.
- the amount of lignin in this cured plant tissue is about 4.4 % or less of the total dry weight content of the cured plant tissue.
- the amount of nicotine is about 2300 ⁇ g or less.
- cured plant tissue containing a reduced level of lignin as compared to control plant tissue in which the amount of lignin has not been reduced, and wherein the amount of matrix-bound NNK is about 1600 ng/g or less and the average particle size is greater than about 1 mm.
- the amount of free NNK is about 200 ng/g or less.
- the amount of NNN is about 1 100 ng/g or less.
- the amount of lignin in this cured plant tissue is about 3 % or less of the total dry weight content of the cured plant tissue.
- the amount of nicotine is about 2100 ⁇ g or less.
- the tobacco plant or the tobacco plant material that is used at the start of the method(s) described herein can comprise or consist or consist essentially of uncured tobacco plant or uncured tobacco plant material or cured tobacco plant or cured tobacco plant material.
- Processes of curing tobacco - such as tobacco leaves, especially, green tobacco leaves are well known to those skilled in the art and include without limitation air-curing, fire-curing, flue-curing and sun-curing.
- the process of curing tobacco depends on the type of tobacco harvested. For example, Virginia flue (bright) tobacco is typically flue-cured, Burley and certain dark strains are usually air-cured, and pipe tobacco, chewing tobacco, and snuff are usually fire-cured.
- tobacco plants or tobacco plant material from any type of tobacco may be used, certain types of tobacco are preferred. Particularly preferred tobacco materials are selected from the group consisting of: flue-Cured, Vietnamese, Burley, Virginia, Maryland, Oriental, or any combination of two or more thereof.
- the shape of the tobacco material is in general not limited. It can be in the form of homogenised tobacco material.
- Tobacco homogenates - such as but not limited to cured tobacco homogenates - may be prepared from tobacco material using various methods known in the art, for example, the tobacco may be in a shredded, granulated, ground or powder form. In certain embodiments, it is desirable not to begin with tobacco material in the ground or powder form since certain mechanical separation methods that can be used to separate lignin can require grinding and/or sieving steps.
- the tobacco material used or obtained may comprise additives that include, but are not limited to, one or more of the following components as well as combinations thereof: flavourants, organic and inorganic fillers (for example, grains, processed grains, puffed grains, maltodextrin, dextrose, calcium carbonate, calcium phosphate, corn starch, lactose, manitol, xylitol, sorbitol, finely divided cellulose, and the like), binders (for example, povidone, sodium carboxymethylcellulose and other modified cellulosic types of binders, sodium alginate, xanthan gum, starch-based binders, gum arabic, lecithin, and the like), colorants (for example, dyes and pigments, including caramel colouring and titanium dioxide, and the like), humectants (for example, glycerin, propylene glycol, and the like), oral care additives, preservatives (for example, potassium sorbate, and the like), syrups (for example,
- the tobacco can be formed into reconstituted tobacco.
- the methods described herein can be used in the preparation of reconstituted tobacco, such as reconstituted tobacco (leaf) sheets. These sheets are paper-like material that can be made from recycled tobacco fines, tobacco stems and "class tobacco", which consists of tobacco particles generally less than 30 mesh in size that are collected at any stage of tobacco processing.
- the reconstituted tobacco can be made by extracting the soluble chemicals in the tobacco by-products, processing the leftover tobacco fibers from the extraction into a paper, and then reapplying the extracted materials in concentrated form onto the paper.
- Reconstituted tobacco can generally be formed in a variety of ways. For instance, in one embodiment, band casting can be utilised to form the reconstituted tobacco.
- Band casting typically employs a slurry of finely divided tobacco parts and a binder that is coated onto a steel band and then dried. After drying, the sheet is blended with natural tobacco strips or shredded and used in various tobacco products, including as a cigarette filler.
- Some examples of processes for producing reconstituted tobacco are described in US 3,353,541 , US 3,420,241 , US 3,386,449, US 3,760,815 and 4,674,519. Reconstituted tobacco can also be formed by a papermaking process.
- reconstituted tobacco Some examples of processes for forming reconstituted tobacco according to this process are described in US 3,428,053, US 3,415,253, US 3,561 ,451 , US 3,467,109, US 3,483,874, US 3,860,012, US 3,847,164, US 4,182,349, US 5,715,844, US 5,724,998; and US 5,765,570.
- the formation of reconstituted tobacco using papermaking techniques can involve the steps of mixing tobacco with water, extracting the soluble ingredients therefrom, concentrating the soluble ingredients, refining the tobacco, forming a web, reapplying the concentrated soluble ingredients, drying, and threshing.
- Various ingredients - such as flavour or colour treatments - can be applied to the web.
- the tobacco obtained or obtainable by the methods described herein may be formed into a tobacco sheet - such as a reconstituted tobacco sheet.
- the method may comprise the steps of: (a) obtaining tobacco material - such as a tobacco homogenate - according to the methods described herein; (b) preparing a slurry of tobacco homogenate; (c) casting the slurry of the tobacco homogenate; and (d) drying the slurry of the tobacco homogenate to form a reconstituted tobacco sheet.
- the method may comprise the steps of: (a) obtaining tobacco material - such as a tobacco homogenate - according to the methods described herein and preparing a tobacco slurry; (b) casting the slurry of the tobacco homogenate; and (c) drying the slurry of the tobacco homogenate to form a tobacco sheet.
- the step of casting the slurry of the tobacco homogenate may be performed using any of the casting or paper making processes that are known in the art.
- casting processes are described in US 5,724,998 and US 5,584,306; paper-making processes are described in US 4,341 ,228; US 5,584,306 and US 6,216,706.
- Casting processes typically include casting the slurry onto a continuous stainless steel belt, drying the cast slurry to form a reconstituted tobacco sheet and removing said sheet.
- Paper-making processes typically include casting the aqueous slurry from a head box onto a wire screen for forming the desired sheet. The aqueous slurry may be separated into a soluble portion and a fibrous portion. Water is drained from the fibrous portion and a sheet is so-formed is subsequently treated and dried.
- the tobacco slurries may further comprise one or more binders - such as gums and pectins.
- tobacco slurries that are used to prepare reconstituted tobacco sheets may further comprise common additives that include, but are not limited to, one or more of the following components as well as combinations of these: wood cellulose fibers, aerosol formers, sugars, and flavourants and binders. Additives of the list described above are known to those having skill in the art and may be present in these aqueous slurries in amounts and in forms known in the art.
- the reconstituted tobacco sheets described herein may be cut in a similar fashion as whole leaf tobacco to produce tobacco filler suitable for cigarettes and other tobacco products.
- the reconstituted tobacco sheets described herein may be further trashed or flayed with mechanical fingers into sized pieces similar to natural tobacco lamina strips or cut into diamond shaped pieces, between about 50 to 100 mm on a side.
- the reconstituted tobacco sheet pieces described herein may be further blended with other tobaccos such as flue-cured tobacco, Burley tobacco, Maryland tobacco, Oriental tobacco, rare tobacco, specialty tobacco, expanded tobacco and the like.
- the precise amount of each type of tobacco within a tobacco blend used for the manufacture of a particular cigarette brand varies from brand to brand.
- a method for blending tobacco in which at least two different types of tobacco are blended so as to form a tobacco blend.
- the various tobacco blends have different recipes for blending different tobacco types.
- Tobacco types can be, by way of example, Burley, Flue Cured, Oriental, Bright and Reconstituted tobacco. Burley, Flue Cured and Oriental tobacco are specific types of tobacco, while Bright tobacco is a pre-blend of Flue Cured and Oriental tobacco.
- a first (type of) cured tobacco plant material is provided and the amount of lignin therein is reduced. Any of the methods described herein can be used to reduce the amount of lignin.
- the total and/or matrix-bound NNK content of the first cured tobacco plant material can be measured and cured tobacco plant material in which the total and/or matrix-bound NNK content is reduced as compared to first cured tobacco plant material initially provided can be selected for further use.
- a second cured tobacco plant material which has a higher total and/or matrix-bound NNK content than the total and/or matrix-bound NNK of the first cured tobacco plant material is next provided.
- the total and/or matrix- bound NNK content of this material may already be known so measurement of these values will not be required. In other embodiments, the total and/or matrix-bound NNK content of this material may not be known and so measurement will be required.
- measuring the total and/or matrix-bound NNK content in the second cured tobacco plant material is an optional step in this method.
- the first and second cured tobacco plant materials obtained from these steps can be blended together using processes that are well known in the art.
- the total and/or matrix-bound NNK content in the final blended tobacco plant material can be measured.
- a blended tobacco plant material can be obtained in which the total and/or matrix-bound NNK content of the final blended tobacco plant material is lower than the second cured tobacco plant material.
- this method can be used to provide a blend of tobacco material in which the overall NNK content of the blend is reduced.
- the tobacco material in which the amount of lignin therein has been reduced is used to dilute or reduce the overall NNK content in the blended tobacco material.
- the tobacco material obtained or obtainable according to this disclosure can also be used in tobacco cut filler and in a smoking article formed from a tobacco rod of the cut filler.
- cut filler tobacco products for smoking articles are formed predominantly from the lamina portion of the tobacco leaf, which is separated from the stem portion of the leaf during a threshing process. Much of the stem portion that remains after the lamina has been removed and separated is not used.
- some tobacco stems can be added back into the cut filler together with the lamina.
- the stems are often first subjected to one or more treatment procedures, which can include the procedures described herein.
- the rolling step can be carried out on tobacco stems that have been subjected to the method of the present disclosure.
- the stems can be rolled to a desired thickness - such as a mean thickness of about 0.6 mm to 0.8 mm.
- the stems can expand to a final thickness of about 0.8 mm to about 1 .0 mm.
- the stems are dried and transferred to the tobacco production plant, where they are cut and added to the tobacco cut filler.
- the rolling step may alternatively be incorporated as part of the on-line production process for cut filler.
- the moisture content of the tobacco stems is about 28 % to about 34 % oven volatiles prior to rolling in order to prevent damage to the structure of the stems.
- the tobacco stems can be conditioned prior to rolling in order to increase the moisture content to this level.
- Known processes for conditioning tobacco stems involve contacting the stems with water, steam or a mixture of water and steam. In methods where the rolling step is incorporated on-line and dried stems are used, the conditioning step will typically take longer and may require a soaking step in which the stems are soaked in water for a number of hours prior to rolling.
- the tobacco stems can be rolled using a one-step rolling process to reduce the thickness of the stems to the desired mean thickness. After rolling, the stems can be cut to a cut width of between 0.1 mm and 0.2 mm. The cut rolled stems are then optionally expanded using known stem expansion techniques, and then dried.
- the stems are pre-rolled and dried, it will typically be necessary to condition the stems prior to cutting in order to increase the moisture content of the tobacco stems back to between 28 % and 34 % oven volatiles. This increases the pliability of the tobacco stems in order to limit damage or breakage of the stems during cutting.
- the cut rolled stems are combined with tobacco cut lamina and any additional tobacco materials in order to form cut filler having at least 5 % by weight of the cut rolled tobacco stems.
- a method of treating tobacco material - such as tobacco stems - for use in tobacco cut filler comprising the steps of: (a) performing the method as described herein; (b) rolling the tobacco material; (c) cutting the rolled tobacco material; and (d) optionally drying the cut rolled stems.
- the rolled tobacco stems can be combined with tobacco lamina such that the steps are carried out on the combined tobacco stems and lamina.
- the cutting step can comprise cutting the rolled stems to a cut width of between about 0.3 mm and 1.3 mm.
- the method can comprise the steps of: removing stems from the tobacco leaf; cutting the stems to an average length of between about 15 mm and 80 mm; and rolling the stems to a thickness of between 0.1 mm and 0.5 mm.
- a method of producing cut filler comprising rolled tobacco stems is also provided, the method comprising: treating tobacco stems using the method described herein; and blending the treated stems with at least one type of tobacco lamina, expanded tobacco or reconstituted tobacco to produce cut filler.
- the tobacco cut filler obtained or obtainable by this method can comprise at least 60 %, and preferably at least 80 % by weight tobacco lamina having a mean cut width between 0.8 mm and 1 .1 mm, suitably, about 0.9 mm, and a mean thickness of about 0.2 mm.
- the tobacco cut filler can comprise up to 95 % by weight tobacco lamina with a mean cut width between about 0.8 mm and 1 .1 mm, more suitably about 0.9 mm, and a mean thickness of about 0.2 mm.
- the particles of tobacco lamina in the cut filler are therefore of similar dimensions to the particles of tobacco stem. As such, the tobacco stems are not visually distinct from the tobacco lamina, even at a high inclusion rate.
- the blend of tobacco stems and lamina can advantageously be transported and processed effectively without significant settling of the stems.
- the mean cut width of the cut rolled tobacco stems is within about 0.1 mm, more suitably within about 0.05 mm of the mean thickness of the tobacco lamina in the cut filler.
- Cut fillers may be incorporated into a variety of smoking articles.
- the cut filler may be used in the tobacco rod of a combustible smoking article, such as a filter cigarette, cigarillo or cigar.
- the cut filler may be used to provide the tobacco aerosol generating substrate in a distillation based smoking article, or an electrically heated smoking system.
- the cut filler may be used as a roll- your-own product, or loose tobacco product for example, for use in a pipe.
- the tobacco material can be incorporated into various consumable products - such as tobacco products. Also encompassed are methods for making such tobacco products.
- Tobacco products include without limitation smoking articles or smokable articles and smokeless tobacco products, including non-combustible products, heated products, and aerosol-generating products.
- Non- limiting examples of smoking or smokable articles include cigarettes, cigarillos, cigars and pipe tobaccos.
- Non-limiting examples of smokeless tobacco products include chewing tobaccos, snuffs, and substrates for use in aerosol-generating products.
- Smokeless tobacco products may comprise tobacco in any form, including as dried particles, shreds, granules, powders, or a slurry, deposited on, mixed in, surrounded by, or otherwise combined with other ingredients in any format, such as flakes, films, tabs, foams, or beads.
- Liquid contents of smokeless tobacco products can be contained in a device or enclosed in a form, such as beads, to preclude interaction with a water- soluble wrapper.
- the wrapper may be shaped as a pouch to partially or completely enclose tobacco-incorporating compositions, or to function as an adhesive to hold together a plurality of tabs, beads, or flakes of tobacco.
- Exemplary materials for constructing a wrapper include film compositions comprising HPMC, CMC, pectin, alginates, pullulan, and other commercially viable, edible film-forming polymers.
- Other wrapping materials may include pre-formed capsules produced from gelatin, HPMC, starch/carrageenan, or other commercially available materials.
- Such wrapping materials may include tobacco as an ingredient.
- Wrappers that are not orally disintegrable may be composed of woven or nonwoven fabrics, of coated or uncoated paper, or of perforated or otherwise porous plastic films. Wrappers may incorporate flavouring or colouring agents.
- Smokeless products can be assembled together with a wrapper utilizing any method known to persons skilled in the art of commercial packaging, including methods such as blister packing, in which a small package can be formed by a vertical form/fill/seal packaging machine.
- the amount of matrix-bound NNK in these smokable articles, smokeless products and aerosols and the like may be at least about 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, and 100% lower - such as about 200% or 300% lower - when compared to consumable products derived from control tobacco plant material.
- the amount of free-NNK may be substantially unchanged.
- the amount of matrix-bound NNK in these smokable articles, smokeless products and aerosols and the like may be about 3500 ng/g or less, or about 3000 ng/g or less, or about 2500 ng/g or less, or about 2000 ng/g or less, or about 1500 ng/g or less, or about 1000 ng/g or less, or about 500 ng/g or less.
- the amount of free NNK in these smokable articles and smokeless products and the like may be about 330 ng/g or less, about 300 ng/g or less, about 250 ng/g or less, about 200 ng/g or less, about 150 ng/g or less, about 100 ng/g or less or about 50 ng/g or less.
- the amount of NNN in these smokable articles, smokeless products and aerosols and the like may be about 1700 ng/g or less, about 1500 ng/g or less, about 1300 ng/g or less, about 1 100 ng/g or less, about 1000 ng/g or less, or about 500 ng/g or less.
- the amount of nicotine in these smokable articles and smokeless products and the like may be about 2600 ⁇ g or less, about 2300 ⁇ g or less, or about 2100 ⁇ g or less, or about 2000 ⁇ g or less 1900 ⁇ g or less, or about 1800 ⁇ g or less.
- the amount of lignin in these smokable articles and smokeless products and the like may about 6.5 % or less of the total dry weight content of the cured plant tissue, about 6 % of the total dry weight content of the cured plant tissue, about 5 % of the total dry weight content of the cured plant tissue, about 4 % of the total dry weight content of the cured plant tissue or about 3 % of the total dry weight content of the cured plant tissue.
- the amount of matrix-bound NNK in these smokable articles and smokeless products and the like is about 3500 ng/g or less, the amount of free NNK is about 300 ng/g or less, the amount of NNN is about 1700 ng/g or less, the amount of lignin is about 6.4 % or less of the total dry weight content of the cured plant tissue, and the amount of nicotine is about 2600 ⁇ g or less.
- the smokable articles or smokeless products and the like comprise about 3500 ng/g or less of matrix-bound NNK.
- the amount of free NNK is about 300 ng/g or less.
- the amount of NNN is about 1700 ng/g or less.
- the amount of lignin in is about 6.4 % or less of the total dry weight content of the cured plant tissue.
- the amount of nicotine is about 2600 ⁇ g or less.
- the average particle size is about 0.5 mm or greater.
- the smokable articles or smokeless products and the like comprise about 1900 ng/g or less matrix-bound NNK.
- the amount of free NNK is about 250 ng/g or less.
- the amount of NNN is about 1270 ng/g or less.
- the amount of lignin in this cured plant tissue is about 4.4 % or less of the total dry weight content of the cured plant tissue.
- the amount of nicotine is about 2300 ⁇ g or less.
- the average particle size is between about 0.85 mm and about 1 mm.
- the smokable articles or smokeless products and the like comprise about 1600 ng/g or less matrix-bound NNK.
- the amount of free NNK is about 200 ng/g or less.
- the amount of NNN is about 1 100 ng/g or less.
- the amount of lignin in this cured plant tissue is about 3 % or less of the total dry weight content of the cured plant tissue.
- the amount of nicotine is about 2100 ⁇ g or less.
- the average particle is greater than about 1 mm.
- the tobacco material can be derived from tobacco plants, which include plants of the genus Nicotiana, various species of Nicotiana, including N. rustica and N. tabacum.
- the tobacco material can be derived from varieties of Nicotiana species, commonly known as flue or bright varieties, Burley varieties, dark varieties and oriental/Turkish varieties.
- the tobacco material is derived from a Burley, Virginia, flue-cured, air-cured, fire-cured, Oriental, or a dark tobacco plant.
- the tobacco material is derived, for example, from one or more of the following varieties: N. tabacum AA 37-1 , N. tabacum B 13P, N. tabacum Xanthi (Mitchell-Mor), N.
- N. acaulis for example, LA B21 , LN KY171 , Tl 1406, Basma, Galpao, Perique, Beinhart 1000-1 , and Petico.
- Other species include N. acaulis, N. acuminate, N. acuminate var. multiflora, N. alata, N. amplexicaulis, N. arentsii, N. benavidesii, N. benthamiana, N. bigelovii, N. bonariensis, N. cavicola, N. clevelandii, N. cordifolia, N. corymbosa, N. debneyi, N. excelsior, N. forgetiana, N. fragrans, N. glauca, N.
- glutinosa N. goodspeedii, N. gossei, N. hybrid, N. ingulba, N. kawakamii, N. knightiana, N. langsdorffii, N. linearis, N. longiflora, N. megalosiphon, N. miersii, N. noctiflora, N. nudicaulis, N. obtusifolia, N. occidentalis, N. occidentalis subsp. hesperis, N. otophora, N. paniculata, N. pauciflora, N. petunioides, N. plumbaginifolia, N. quadrivalvis, N. raimondii, N. repanda, N.
- Nicotiana tabacum varieties include Burley type, dark type, flue-cured type, and Oriental type tobaccos.
- Non-limiting examples of varieties or cultivars are: BD 64, CC 101 , CC 200, CC 27, CC 301 , CC 400, CC 500, CC 600, CC 700, CC 800, CC 900, Coker 176, Coker 319, Coker 371 Gold, Coker 48, CD 263, DF91 1 , DT 538 LC Galpao tobacco, GL 26H, GL 350, GL 600, GL 737, GL 939, GL 973, HB 04P, HB 04P LC, HB3307PLC, Hybrid 403LC, Hybrid 404LC, Hybrid 501 LC, K 149, K 326, K 346, K 358, K394, K 399, K 730, KDH 959, KT 200
- NNK concentrations are again measured by UPLC- MS/MS. From these values, the “total NNK” concentration in the samples can be calculated.
- the “matrix-bound NNK” concentration is the difference between the “total NNK” and the “free NNK” concentrations.
- An alternative method for "total-NNK” extraction comprises acidification of the extraction mixtures with concentrated HCI (for example, 3 mL of 37% HCI added to 30 mL) and incubation for 48 hours at 80°C.
- the acidic extracts are neutralised before filtration and UPLC analysis by adding NaOH solution (6N, 40 ⁇ ) and magnesium hydroxide suspension (10%; 40 ⁇ ) to 320 ⁇ of extract.
- the column used is Waters Acquity BEH C18, 1.7 ⁇ , 2.1 50 mm.
- the eluents used are: (A) ammonium bicarbonate (10mM; adjusted to pH 9.8 with ammonia) + 2% (v/v) acetonitrile; (B) acetonitrile.
- the gradient used is 0 min - 5 % B; 0.5 min - 5% B; 3.3 min - 18.3 % B.
- the flow that is used is 0.5 mL/min.
- the column temperature that is used is 50°C.
- Figure 1 show the distribution of free NNK, matrix-bound NNK and lignin in lignified (L) and non-lignified (NL) tissues of cured Burley stems.
- Figure 2 is a cross-section of a hydrated cured Burley stem showing lignified (L) and non-lignified (NL) tissues. Lignified tissue is stained red with phloroglucinol.
- Figure 3 shows the matrix-bound NNK content of lignified and non-lignified tissues of green midribs after nitrosating with sodium nitrite solution.
- Example 5 Enrichment of a fraction with low bound-NNK content from Burley Stem by freeze-drying, grinding and size separation
- a sample of Burley Stems (52 g) is humidified with water (350 mL) and freeze-dried.
- a part of the resulting material (12 g) is ground by shaking with steel balls (2 balls, diameter 2 cm; 300 rpm; 15 min) and separated with a sieve shaker into fractions of different particle size ranging from greater than 1 mm to less than 0.25 mm.
- Figure 4 and Table 1 show the free- and matrix-bound NNK, NNN, lignin and nicotine levels in sieving fractions of ground freeze-dried Burley stems.
- the analysis of free- and matrix-bound NNK in Figure 5 and Table 1 indicates that both the lignin content (as % dry weight of each fraction) and the matrix-bound NNK content is decreased in the fractions with particle size of greater than 0.5 mm, including fractions with particle size of 0.5 mm to 0.85 mm, 0.85 mm to 1 mm and greater than 1 mm.
- Figure 5 shows that lignin content correlates well with matrix-bound NNK thereby confirming the co-localisation of lignin and matrix-bound NNK.
- the relative distribution of matrix-bound NNK is measured in sclerenchymatic and non- sclerenchymatic tissue of TN90 midribs.
- the prediction of matrix-bound NNK being bound to lignin predicts a higher concentration of this precursor in the lignified sclerenchymatic tissue.
- the relative distribution of free and matrix-bound NNK in sclerenchymatic and non- sclerenchymatic tissue of (cured) Burley stems is investigated.
- the midribs (only the proximal halves) of 15 mature TN90 leaves are manually separated in sclerenchymatic tissue (S) (the "center” of the midrib) and non-sclerenchymatic tissue (NS). Both are freeze-dried and finely ground.
- S sclerenchymatic tissue
- NS non-sclerenchymatic tissue
- the water-insoluble fraction of the two materials is determined by extracting 1 g, each, three times with 40 mL of methanol/water 1 :3 (room temperature for 1 hour) and weighing the insoluble material (designated SW and NSW) after freeze-drying.
- Finely powdered plant material (-20 mg) is extracted by shaking at room temperature for 45 minutes with methanol/water (4:1 ) containing PON-methyl-d 3 as an internal standard (200 ng/mL). After filtration (0.2 ⁇ ) samples are subjected to LC-MS analysis using the following conditions: Column: Acquity UPLC BEH C18 column (1 .7 ⁇ , 50 x 2.1 mm; Waters); Column temperature: 50 °C; Eluents: Aqueous ammonium bicarbonate adjusted to pH 9.8 using NH 3 with acetonitrile (98:2, v/v; eluent A); acetonitrile (eluent B); Gradient: 0 min - 0 % B, 0.5 mL/min; 0.5 min - 0 % B, 0.5 mL/min; 6 min - 30 % B, 0.5 mL/min; MS detection: PON m/z 179.2 a m/z 106.1
- PON and nicotine are eluted after 2.6 and 4.1 minutes, respectively.
- the peak area at 260 nm and external calibration is used.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacture Of Tobacco Products (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13198191 | 2013-12-18 | ||
PCT/EP2014/078607 WO2015091880A1 (en) | 2013-12-18 | 2014-12-18 | Methods for reducing matrix-bound nicotine-derived nitrosamine ketone in tobacco plant material |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3082478A1 true EP3082478A1 (en) | 2016-10-26 |
EP3082478B1 EP3082478B1 (en) | 2022-03-23 |
Family
ID=49911232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14824834.7A Active EP3082478B1 (en) | 2013-12-18 | 2014-12-18 | Methods for reducing matrix-bound nicotine-derived nitrosamine ketone in tobacco plant material |
Country Status (12)
Country | Link |
---|---|
US (2) | US20160295907A1 (en) |
EP (1) | EP3082478B1 (en) |
JP (1) | JP6596000B2 (en) |
KR (1) | KR102329410B1 (en) |
CN (1) | CN105764359B (en) |
AP (1) | AP2016009294A0 (en) |
BR (1) | BR112016012407B1 (en) |
CA (1) | CA2931761A1 (en) |
MX (1) | MX2016007987A (en) |
PH (1) | PH12016500819A1 (en) |
RU (1) | RU2671616C1 (en) |
WO (1) | WO2015091880A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3041507B1 (en) * | 2015-09-25 | 2019-08-30 | Ltr Industries | RECONSTITUTED TOBACCO FOR DEVICES HEATING TOBACCO WITHOUT BURNING IT |
BR112018074216B1 (en) * | 2016-05-27 | 2022-11-22 | Philip Morris Products S.A | METHOD FOR THE PRODUCTION OF HOMOGENIZED TOBACCO MATERIAL |
JP2020513742A (en) | 2016-12-30 | 2020-05-21 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | Nicotine-containing sheet |
MX2019007464A (en) | 2016-12-30 | 2019-09-09 | Philip Morris Products Sa | Nicotine and cellulose containing sheet. |
DE102019129154A1 (en) | 2019-10-29 | 2021-04-29 | Kevin Althaus | Thermally conductive tobacco composition and methods of providing the tobacco composition and use |
DE202019105999U1 (en) | 2019-10-29 | 2019-11-11 | Kevin Althaus | Thermally conductive tobacco composition and use |
GB202012747D0 (en) * | 2020-08-14 | 2020-09-30 | Nicoventures Trading Ltd | Aerosol generation |
WO2023145126A1 (en) * | 2022-01-26 | 2023-08-03 | 日本たばこ産業株式会社 | Method for producing tobacco raw material, and tobacco raw material |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2010545C1 (en) * | 1992-04-22 | 1994-04-15 | Товарищество с ограниченной ответственностью "Сфинкс" | Cigarette filter |
DE19543263C2 (en) * | 1995-11-20 | 2001-04-19 | Bat Cigarettenfab Gmbh | Process and plant for the treatment of tobacco leaves for the production of cut tobacco |
AP1461A (en) * | 1998-09-15 | 2005-09-02 | Star Scient Inc | Tobbacco curing barn. |
DE60116273T2 (en) * | 2000-03-10 | 2006-07-13 | British American Tobacco (Investments) Ltd. | TOBACCO |
CN100518551C (en) * | 2000-10-05 | 2009-07-29 | 施韦策-莫杜特国际公司 | Reduction of nitrosamines in tobacco and tobacco products |
JP2004520818A (en) | 2000-11-10 | 2004-07-15 | ベクター、タバコ、リミテッド | Methods and products for removing carcinogens from tobacco smoke |
US6772767B2 (en) * | 2002-09-09 | 2004-08-10 | Brown & Williamson Tobacco Corporation | Process for reducing nitrogen containing compounds and lignin in tobacco |
WO2005099493A2 (en) * | 2004-04-14 | 2005-10-27 | Philip Morris Products S.A. | Reduction of phenolic compound precursors in tobacco |
SE529463C2 (en) * | 2005-11-07 | 2007-08-14 | Njette Ab | Smoking article e.g. cigarette comprises nicotine obtained from extracted nicotine further processed for its purification by exposing the tobacco material into a subset of washing steps with alkaline and acid |
CN102920009A (en) | 2012-11-07 | 2013-02-13 | 红云红河烟草(集团)有限责任公司 | Method for reducing NNK content in tobacco leaves |
-
2014
- 2014-12-18 KR KR1020167013448A patent/KR102329410B1/en active IP Right Grant
- 2014-12-18 AP AP2016009294A patent/AP2016009294A0/en unknown
- 2014-12-18 CN CN201480064294.2A patent/CN105764359B/en active Active
- 2014-12-18 RU RU2016124655A patent/RU2671616C1/en active
- 2014-12-18 BR BR112016012407-3A patent/BR112016012407B1/en active IP Right Grant
- 2014-12-18 WO PCT/EP2014/078607 patent/WO2015091880A1/en active Application Filing
- 2014-12-18 EP EP14824834.7A patent/EP3082478B1/en active Active
- 2014-12-18 US US15/037,376 patent/US20160295907A1/en not_active Abandoned
- 2014-12-18 CA CA2931761A patent/CA2931761A1/en not_active Abandoned
- 2014-12-18 JP JP2016541392A patent/JP6596000B2/en active Active
- 2014-12-18 MX MX2016007987A patent/MX2016007987A/en unknown
-
2016
- 2016-05-03 PH PH12016500819A patent/PH12016500819A1/en unknown
-
2022
- 2022-09-20 US US17/948,364 patent/US20230028025A1/en active Pending
Non-Patent Citations (2)
Title |
---|
None * |
See also references of WO2015091880A1 * |
Also Published As
Publication number | Publication date |
---|---|
US20230028025A1 (en) | 2023-01-26 |
AP2016009294A0 (en) | 2016-06-30 |
MX2016007987A (en) | 2016-09-19 |
KR102329410B1 (en) | 2021-11-23 |
PH12016500819A1 (en) | 2016-06-13 |
JP2017500048A (en) | 2017-01-05 |
CA2931761A1 (en) | 2015-06-25 |
EP3082478B1 (en) | 2022-03-23 |
WO2015091880A1 (en) | 2015-06-25 |
KR20160094941A (en) | 2016-08-10 |
RU2671616C1 (en) | 2018-11-02 |
US20160295907A1 (en) | 2016-10-13 |
BR112016012407B1 (en) | 2022-02-15 |
JP6596000B2 (en) | 2019-10-23 |
BR112016012407A2 (en) | 2017-08-08 |
CN105764359A (en) | 2016-07-13 |
RU2016124655A (en) | 2018-01-23 |
CN105764359B (en) | 2019-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230028025A1 (en) | Methods for reducing matrix-bound nicotine-derived nitrosamine ketone in tobacco plant material | |
JP7419180B2 (en) | Meltable smokeless tobacco composition | |
US20210345658A1 (en) | Method for treating plants with probiotics | |
US20190313689A1 (en) | Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material | |
EP2713780B1 (en) | Methods for reducing the formation of tobacco specific nitrosamines in tobacco homogenates | |
EP2967127B1 (en) | Methods for reducing one or more tobacco specific nitrosamines in tobacco material | |
JP6324897B2 (en) | Smokeless tobacco products containing pectin ingredients | |
US20120199145A1 (en) | Method for treating an extracted tobacco pulp and tobacco products made therefrom | |
WO2007089613A2 (en) | Nicotiana diversity | |
EP2827727B1 (en) | Method for treating an extracted tobacco pulp and tobacco products made therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20160718 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: VUARNOZ, ALINE Inventor name: SCHALLER, JEAN-PIERRE Inventor name: LANG, GERHARD |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: VUARNOZ, ALINE Inventor name: LANG, GERHARD Inventor name: SCHALLER, JEAN-PIERRE |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20190711 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20211001 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014082955 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1476836 Country of ref document: AT Kind code of ref document: T Effective date: 20220415 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220623 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220623 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1476836 Country of ref document: AT Kind code of ref document: T Effective date: 20220323 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220624 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220725 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220723 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014082955 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 |
|
26N | No opposition filed |
Effective date: 20230102 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230529 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20221231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221218 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221218 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221231 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231220 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20231220 Year of fee payment: 10 Ref country code: IT Payment date: 20231221 Year of fee payment: 10 Ref country code: FR Payment date: 20231221 Year of fee payment: 10 Ref country code: DE Payment date: 20231214 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20141218 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20240101 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220323 |